Stockholders v NDCHealth Corporation

WIN AN iPOD TOUCH!*
Sign Up For Our FREE Weekly Alerts




 
General Alerts
General Alerts include all recent cases, recalls and complaints.
Automotive Alerts
Make sure YOUR car has not been recalled and you are safe.
Family Alerts
Keep track of recalls and cases that affect you and your children.
Health and Medical Alerts
Are the prescription drugs and medical devices YOU use safe?
Consumer Alerts
Get notified about recalled products around your home.
Environmental Alerts
Keep up with pollution and contamination that may affect you.
Financial Alerts
Keep an eye on your investments.
 
 

NDCHealth Corporation Accused of Failing to Follow GAAP

Case ID: 3338
Category: Stocks
 
Last Update: 08/08/2005
Country:
 

Several class actions have been filed against health information purveyor NDCHealth Corporation (NYSE: NDC) and certain of its officers and directors by stockholders who purchased the company's common stock between October 1, 2003, and March 31, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

Throughout the applicable period, the defendants issued quarter after quarter of strong financial results. The defendants allegedly failed to disclose that these stellar financial results were only made possible through improper revenue recognition practices in violation of Generally Accepted Accounting Principles (GAAP). On April 1, 2004, before the market opened, the defendants shocked the market by announcing that NDC would delay the release of its fiscal third-quarter financial results because of a review of some aspects of its revenue-recording procedures. The review related to the timing of sales recognition in its value-added reseller channel in NDC's physician business unit.

In response to the news concerning NDC's previously undisclosed accounting issues, the price of NDC stock dropped nearly 20% to close at $22.70 on unusually large trading volumes of nearly 4.8 million shares traded -- far greater than NDC's average daily trading volume of about 298,000 shares.

If you purchased securities issued by NDCHealth Corporation during the applicable period, you may request appointment by the court as a lead plaintiff if you do so by June 7, 2004. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the court must determine that your claim is typical of the claims of other class members, and that you will adequately represent the class. Under certain circumstances, one or more class members may together serve as lead plaintiffs. Your ability to share in any recovery is not affected by the decision whether or not to serve as a lead plaintiff. You may retain any counsel of your choice to serve as you in this action, or you may choose to do nothing, and remain in the class as a silent member.

Browse Class Actions in the following categories.

 
GO
 
 
 
Class Action Lawsuit Center || Product Recall Center || Consumer Complaint Center || About LawCash || Privacy Policy || Terms & Conditions
LawCash® is a service of skyMedia, llc © 2000 - 2010 Copyright. All rights reserved skyMedia, llc.